Disease Area

filter
  • 359
  • 4
  • 46
  • 14
  • 21
  • 21
  • 11
  • 73
  • 20
  • 8
  • 16
  • 60
  • 22
  • 5
  • 38
  • 200
  • 200
  • 212
  • 1
  • 13
  • 2
  • 2
  • 15
  • 1
  • 3
  • 10
  • 17
  • 2
  • 4
  • 4
  • 4
  • 1
  • 2
  • 2
  • 1
  • 5
  • 1
  • 1
  • 39
  • 1
  • 5
  • 6
  • 3
  • 16
  • 20
  • 4
  • 24
  • 3
  • 293
  • 1
  • 1
  • 1
  • 2
  • 1
  • 2
  • 1
  • 2
  • 1
  • 2
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 3
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 2
  • 3
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 1
  • 8
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 9
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • 1
  • 3
  • 1
  • 1
  • 3
  • 1
  • 2
  • 1
  • 1
  • 1
  • 3
  • 1
  • 1
  • 2
  • 1
  • 1
  • 3
  • 1
  • 1
  • 1
  • 2
  • 9
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 7
  • 1
  • 1
  • 1
  • 2
  • 1
  • 1
  • 1
  • Liver disease & HCC x
Disease Area
•Articles
Broadening diagnostic options for better patient care with a HCV Ag-Ab dual assay
Alap Christy, Mandakini Sarmah
Disease Area
•Articles
Shaping the future of Hepatitis C diagnosis: the role of HCV Ag-Ab dual assays
Ashish Kumar, Mandakini Sarmah
At CGMH Linkou in Taiwan, workflow optimisation increased lab efficiency, allowing addition of PIVKA-II testing
Disease Area
•Articles
At CGMH Linkou in Taiwan, workflow optimisation increased lab efficiency, allowing addition of PIVKA-II testing
Chia Ni Lin, Po Wen Gu
Managing assay changes at a Japanese lab: a case study in PIVKA-II transition
Disease Area
•Articles
Managing assay changes at a Japanese lab: A case study in PIVKA-II transition
Nobuhiro Sato
Dr John Ward on expanding HCV testing to achieve elimination goals
Disease Area
•Articles
Dr John Ward on expanding HCV testing to achieve elimination goals
John Ward
New HBV biomarkers support virus reduction efforts
Disease Area
•Articles
New HBV biomarkers support virus reduction efforts
Alex Thompson, Mark Douglas
Is Hepatitis B entering the era of personalised medicine_thumbnail
Disease Area
•Articles
Is Hepatitis B entering the era of personalised medicine?
Alex Thompson, Mark Douglas
PIVKA-II drives early detection of HCC in Vietnam
Disease Area
•Articles
PIVKA-II drives early detection of HCC in Vietnam
Bao Toan Nguyen
Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi
Disease Area
•Articles
Pakistan’s national HCV elimination programme: insights from Dr Huma Qureshi
Huma Qureshi
HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas
Disease Area
•Articles
HCV elimination in Sindh: insights from Prof Muhammad Sadik Memon and Dr Zaigham Abbas
Muhammad Sadik Memon, Zaigham Abbas
Tackling HCV in Punjab: local experts share strategies for success
Disease Area
•Articles
Tackling HCV in Punjab: local experts share strategies for success
Ghias Un Nabi Tayyab, Muhammad Umar
Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming
Disease Area
•Articles
Liver disease and patient advocacy in Taiwan: Q&A with Prof Yang Pei-Ming
Wendy Wang, Yang Pei-Ming
Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance
Disease Area
•Articles
Liver cancer in Japan: Dr Shun Kaneko on HCC screening and surveillance
Shun Kaneko
Disease Area
•Articles
HCC in Thailand: Dr Terachai Songkiatkawin on improving liver cancer diagnostics and treatment
Terachai Songkiatkawin
HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands
Disease Area
•Articles
HCV elimination in Northern Pakistan: Prof Aamir Khan on treating patients in KPK province and the Afghan borderlands
Aamir Khan
Liver disease in Asia Pacific: Q&A with Prof Pierce Chow
Disease Area
•Articles
Liver disease in Asia Pacific: insights from Prof Pierce Chow
Pierce Chow

Related Contributors

1 2
Scroll to Top